Lyphochek 665X
Lyphochek 665X is a tricyclic antidepressant IVD (FDA Class I; FDA product code DIF, Drug Mixture Control Materials) made by Bio-Rad Laboratories, cleared under FDA 510(k) K955153 on 5 Feb 1996 and listed in FDA GUDID since 9 Jan 2017 (UDI-DI 00847661002147), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00847661002147 | Date9 Jan 2017 | StatusListed |
| United States | FDA 510(k)SESE | NumberK955153 | Date5 Feb 1996 | StatusActive |
Official records
- AccessGUDID record 00847661002147
- FDA 510(k) database K955153
From the FDA record
- Device description
- Lyphochek Benzo/TCA Control- Set B MiniPak (A human serum assayed benzodiazepines and TCA control.)
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K955153 decided 5 Feb 1996 Active
- FDA GUDID UDI-DI 00847661002147 listed 9 Jan 2017 Listed
Timeline
- Cleared FDA 510(k) K955153
- Listed FDA GUDID 00847661002147
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Lyphochek
- Generic name
- Tricyclic antidepressant IVD, control
- Model / Ref / Catalog
- 665X
- Primary DI / UDI-DI
- 00847661002147
- 510(k) Number
- FDA product code
- DIF
- GMDN term
- Tricyclic antidepressant IVD, control
- Device class
- Class I
- Regulation number
- 862.3280
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code DIF (DRUG MIXTURE CONTROL MATERIALS).
- DOA LIQUID MULTI-ANALYTE DRUGS OF ABUSE CONTROLS by Medical Analysis Systems, Inc.
- DETECTABUSE(TM) by BIOCHEMICAL DIAGNOSTICS INC
- QAC CONTROL by THE QUALITY ASSURANCE SERVICE CORP.
- DRUGS OF ABUSE CONTROLS by E.I. Dupont DE Nemours & Co., Inc.
- TDCONTROL LIQUID MULTI-ANALYTE THERAPEUTIC DRUG by Medical Analysis Systems, Inc.
- LYPHOCHEK URINE TOXICOLOGY CONTROL - LOW by Bio-Rad
- STRATUS TDM CONTROL, LEVELS I, II, III by American Dade
- Immunalysis 04Z41-10 by Immunalysis Corporation
- TRICYCLIC ANTIDEPRESSANTS by UTAK Laboratories Inc.
- ACETAMINOPHEN/SALICYLATE CONTROL by Clin Tech Diagnostics Corp.